Enovis (ENOV) announced the appointment of Damien McDonald as CEO, effective May 12. McDonald will also join the Enovis Board of Directors following the conclusion of the company’s 2025 Annual Meeting of Stockholders on May 21. He will succeed Matt Trerotola, who previously announced his intention to retire as CEO and has informed the Board that he will not stand for re-election at the Annual Meeting. McDonald joins Enovis with more than 35 years of experience in the medical device industry. Most recently, he served as CEO of LivaNova (LIVN).
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
- Enovis CEO Matthew Trerotola Announces Retirement Plan
- Positive Outlook for Enovis: Strong Market Position and Strategic Growth Initiatives
- Enovis Positioned for Growth: Buy Rating Highlights Strategic Execution and Undervaluation
- Enovis Corporation Reports Strong Growth Amid Challenges
- Enovis price target lowered to $59 from $62 at Wells Fargo
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue